These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7657490)

  • 21. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection.
    Marrelli D; Roviello F; De Stefano A; Fotia G; Giliberto C; Garosi L; Pinto E
    J Am Coll Surg; 2004 Jan; 198(1):51-8. PubMed ID: 14698311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postsurgical surveillance for recurrence of UICC stage I colorectal carcinoma: is follow-up by CEA justified?
    Yamamoto S; Akasu T; Fujita S; Moriya Y
    Hepatogastroenterology; 2005; 52(62):444-9. PubMed ID: 15816454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical efficacy of CA 72-4 as serum marker for gastric cancer in comparison with CA19-9 and CEA.
    Kodama I; Koufuji K; Kawabata S; Tetsu S; Tsuji Y; Takeda J; Kakegawa T
    Int Surg; 1995; 80(1):45-8. PubMed ID: 7657491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and pathologic evaluation of patients with recurrence of colorectal cancer five or more years after curative resection.
    Cho YB; Chun HK; Yun HR; Lee WS; Yun SH; Lee WY
    Dis Colon Rectum; 2007 Aug; 50(8):1204-10. PubMed ID: 17566830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EIPL (extensive intraoperative peritoneal lavage) therapy significantly reduces peritoneal recurrence after pancreatectomy in patients with pancreatic cancer.
    Yamamoto K; Shimada S; Hirota M; Yagi Y; Matsuda M; Baba H
    Int J Oncol; 2005 Nov; 27(5):1321-8. PubMed ID: 16211228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carcinoembryonic antigen and patterns of recurrence after curative resection of the colorectal cancer.
    Park JY; Lee KH
    Hepatogastroenterology; 2007; 54(79):1966-9. PubMed ID: 18251140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Multivariate regression analysis of recurrence following curative surgery for colorectal cancer].
    Liang JL; Wan DS; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Wu XJ
    Ai Zheng; 2004 May; 23(5):564-7. PubMed ID: 15142455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CEA, CA 50 and CA 242 in patients surviving colorectal cancer without recurrent disease.
    Engarås B; Kewenter J; Nilsson O; Wedel H; Hafström L
    Eur J Surg Oncol; 2001 Feb; 27(1):43-8. PubMed ID: 11237491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A small rise in CEA is sensitive for recurrence after surgery for colorectal cancer.
    Irvine T; Scott M; Clark CI
    Colorectal Dis; 2007 Jul; 9(6):527-31. PubMed ID: 17573747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of postoperative survival by preoperative serum concentrations of anti-p53 compared to CEA, CA 50, CA 242 and conventional blood tests in patients with colorectal carcinoma.
    Forslund A; Engarås B; Lönnroth C; Lundholm K
    Int J Oncol; 2002 May; 20(5):1013-8. PubMed ID: 11956598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effectiveness of quarterly assessment of CEA, TPA and GICA serum levels in gastric and colorectal carcinomas: Prospective study of 174 patients undergoing radical surgery].
    Barillari P; Ricci M; Broglia S; Manetti G; Cerasi A; Cesareo S; Calcaterra D; Cioè I; Caronna R; Sammartino P
    Minerva Chir; 1994 Oct; 49(10):953-61. PubMed ID: 7808670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The postoperative recurrence and the occurrence of second primary carcinomas in patients with early gastric carcinoma.
    Yamamoto M; Yamanaka T; Baba H; Kakeji Y; Maehara Y
    J Surg Oncol; 2008 Mar; 97(3):231-5. PubMed ID: 18095298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Serum carcinoembryonic antigen doubling time in patients with recurrent gastrointestinal carcinoma and its relationship to tumor biology and life expectancy].
    Takesue F; Inutsuka S; Nagahama S; Kusumoto H; Korenaga D; Maekawa S; Ikeda T
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():464-8. PubMed ID: 9589054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis.
    Ono M; Sakamoto M; Ino Y; Moriya Y; Sugihara K; Muto T; Hirohashi S
    Cancer; 1996 Sep; 78(6):1179-86. PubMed ID: 8826938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
    Bijelic L; Yan TD; Sugarbaker PH
    Ann Surg Oncol; 2007 Aug; 14(8):2281-8. PubMed ID: 17503156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Peritoneal lavage diagnosis with TRC (transcription reverse transcription concerted reaction) system for prediction of peritoneal recurrence in gastric cancer].
    Hanada H; Fujiwara Y; Sohma I; Nakamura Y; Takeoka K; Iwatani Y; Hidaka Y
    Rinsho Byori; 2007 Nov; 55(11):1002-7. PubMed ID: 18154031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence.
    Holubec L; Topolcan O; Pikner R; Pecen L; Vaclavickova J; Wirthova M; Molacek J; Stieber P; Holdenrieder S; Sen LH; Finek J
    Anticancer Res; 2000; 20(6D):5237-44. PubMed ID: 11326702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Utility of dopa decarboxylase as a novel marker for the detection of peritoneal micro-metastases of gastric cancer with realtime RT-PCR].
    Sakakura C; Takemura M; Miyagawa K; Fukuda K; Shimomura K; Kin S; Nakase Y; Kuriu Y; Nakashima S; Yoshikawa T; Ueda Y; Fujiyama J; Sonoyama T; Okazaki Y; Hayashizaki Y; Hagiwara A; Yamagishi H
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1906-8. PubMed ID: 15553755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of postoperative follow-up and surgical treatment for Krukenberg tumor from colorectal cancers.
    Sakakura C; Hagiwara A; Yamazaki J; Takagi T; Hosokawa K; Shimomura K; Kin S; Nakase Y; Fukuda K; Yamagishi H
    Hepatogastroenterology; 2004; 51(59):1350-3. PubMed ID: 15362750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.